201 related articles for article (PubMed ID: 31678381)
1. New orodispersible mini-tablets for paediatric use - A comparison of isomalt with a mannitol based co-processed excipient.
Lura A; Luhn O; Suarez Gonzales J; Breitkreutz J
Int J Pharm; 2019 Dec; 572():118804. PubMed ID: 31678381
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of two novel co-processed excipients for direct compression of orodispersible tablets and mini-tablets.
Kokott M; Lura A; Breitkreutz J; Wiedey R
Eur J Pharm Biopharm; 2021 Nov; 168():122-130. PubMed ID: 34474110
[TBL] [Abstract][Full Text] [Related]
3. Orally disintegrating mini-tablets (ODMTs)--a novel solid oral dosage form for paediatric use.
Stoltenberg I; Breitkreutz J
Eur J Pharm Biopharm; 2011 Aug; 78(3):462-9. PubMed ID: 21324357
[TBL] [Abstract][Full Text] [Related]
4. Polyols as filler-binders for disintegrating tablets prepared by direct compaction.
Bolhuis GK; Rexwinkel EG; Zuurman K
Drug Dev Ind Pharm; 2009 Jun; 35(6):671-7. PubMed ID: 19274511
[TBL] [Abstract][Full Text] [Related]
5. Transfer and scale-up of the manufacturing of orodispersible mini-tablets from a compaction simulator to an industrial rotary tablet press.
Lura A; Elezaj V; Kokott M; Fischer B; Breitkreutz J
Int J Pharm; 2021 Jun; 602():120636. PubMed ID: 33895296
[TBL] [Abstract][Full Text] [Related]
6. New Orodispersible Mini Tablets of Enalapril Maleate by Direct Compression for Pediatric Patients.
Ortega CA; Favier LS; Cianchino VA; Cifuente DA
Curr Drug Deliv; 2020; 17(6):505-510. PubMed ID: 32384031
[TBL] [Abstract][Full Text] [Related]
7. Impact of lubrication on key properties of orodispersible minitablets in comparison to conventionally sized orodispersible tablets.
Kuck J; Breitkreutz J
Eur J Pharm Biopharm; 2022 Nov; 180():71-80. PubMed ID: 36067955
[TBL] [Abstract][Full Text] [Related]
8. Direct compression and moulding properties of co-extruded isomalt/drug mixtures.
Ndindayino F; Vervaet C; Van den Mooter G; Remon JP
Int J Pharm; 2002 Mar; 235(1-2):159-68. PubMed ID: 11879751
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability of hydrochlorothiazide from isomalt-based moulded tablets.
Ndindayino F; Vervaet C; Van den Mooter G; Remon JP
Int J Pharm; 2002 Oct; 246(1-2):199-202. PubMed ID: 12270622
[TBL] [Abstract][Full Text] [Related]
10. Effect of co-processed excipient type on properties of orodispersible tablets containing captopril, tramadol, and domperidone.
Tranová T; Loskot J; Navrátil O; Brniak W; Mužíková J
Int J Pharm; 2023 Apr; 636():122838. PubMed ID: 36921743
[TBL] [Abstract][Full Text] [Related]
11. Direct compression properties of melt-extruded isomalt.
Ndindayino F; Henrist D; Kiekens F; Van den Mooter G; Vervaet C; Remon JP
Int J Pharm; 2002 Mar; 235(1-2):149-57. PubMed ID: 11879750
[TBL] [Abstract][Full Text] [Related]
12. Orodispersible tablets containing taste-masked solid lipid pellets with metformin hydrochloride: Influence of process parameters on tablet properties.
Petrovick GF; Kleinebudde P; Breitkreutz J
Eur J Pharm Biopharm; 2018 Jan; 122():137-145. PubMed ID: 29106946
[TBL] [Abstract][Full Text] [Related]
13. Downstream drug product processing of itraconazole nanosuspension: Factors influencing tablet material properties and dissolution of compacted nanosuspension-layered sugar beads.
Tan EH; Parmentier J; Low A; Möschwitzer JP
Int J Pharm; 2017 Oct; 532(1):131-138. PubMed ID: 28859940
[TBL] [Abstract][Full Text] [Related]
14. Flexible and precise dosing of enalapril maleate for all paediatric age groups utilizing orodispersible minitablets.
Thabet Y; Walsh J; Breitkreutz J
Int J Pharm; 2018 Apr; 541(1-2):136-142. PubMed ID: 29474896
[TBL] [Abstract][Full Text] [Related]
15. Influence of Prosolv and Prosolv:Mannitol 200 direct compression fillers on the physicomechanical properties of atorvastatin oral dispersible tablets.
Gowda V; Pabari RM; Kelly JG; Ramtoola Z
Pharm Dev Technol; 2015 Jun; 20(4):394-400. PubMed ID: 24397821
[TBL] [Abstract][Full Text] [Related]
16. Impact of fillers on dissolution kinetic of fenofibrate dry foams.
Lenz E; Sprunk A; Kleinebudde P; Page S
Pharm Dev Technol; 2015; 20(5):570-8. PubMed ID: 24901031
[TBL] [Abstract][Full Text] [Related]
17. Application of SeDeM expert systems in preformulation studies of pediatric ibuprofen ODT tablets.
Sipos E; Oltean AR; Szabó ZI; Rédai EM; Nagy GD
Acta Pharm; 2017 Jun; 67(2):237-246. PubMed ID: 28590910
[TBL] [Abstract][Full Text] [Related]
18. Compaction properties of isomalt.
Bolhuis GK; Engelhart JJ; Eissens AC
Eur J Pharm Biopharm; 2009 Aug; 72(3):621-5. PubMed ID: 19327398
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus.
Brniak W; Jachowicz R; Krupa A; Skorka T; Niwinski K
Pharm Dev Technol; 2013; 18(2):464-74. PubMed ID: 22881600
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical design of a new lactose-free coprocessed excipient: application of hydrochlorothiazide as a low solubility drug model.
Viscasillas Clerch A; Fernandez Campos F; Del Pozo A; Calpena Campmany AC
Drug Dev Ind Pharm; 2013 Jul; 39(7):961-9. PubMed ID: 22607083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
